Meperidine Hydrochloride — 50MG/ML, Injection, carton of 25 × 1 mL vials

Meperidine Hydrochloride — 50MG/ML, Injection, carton of 25 × 1 mL vials

Meperidine Hydrochloride is a injection for intramuscular; intravenous; subcutaneous use. Meperidine Hydrochloride Injection is indicated for preoperative medication, support of anesthesia, and obstetrical analgesia. Meperidine Hydrochloride Injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

• Active ingredient or product type: MEPERIDINE HYDROCHLORIDE
• Strength/concentration: 50MG/ML
• Dosage form and route: Injection, Intramuscular; Intravenous; Subcutaneous
• Exact package presentation: carton of 25 × 1 mL vials
• NDC/item number: 0641-6053-25
• Manufacturer: HIKMA PHARMACEUTICALS USA INC
• Storage/handling: Store at 20 ° to 25 °C (68 ° to 77 °F), excursions permitted to 15 ° to 30 °C (59 ° to 86 °F) [See USP Controlled Room Temperature].
• Status: Rx only

Important safety information: Opioid-Induced Hyperalgesia and Allodynia: Opioid-Induced Hyperalgesia (OIH) occurs when an opioid analgesic paradoxically causes an increase in pain, or an increase in sensitivity to pain.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.